P12-12. Analysis of antibody and B cell responses following inoculation with computationally designed HIV-1 2F5 epitope scaffold proteins by Hedestam GB, Kwong PD, Schief W, Baker D, Ofek G, Guenaga J, Dosenovic P, Wyatt RT

P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies by Stamatatos L, Strong R, Montefiori D, Kalyuzhniy O, Ellingson K, Bretz C, Ban YA, Boni E, Lagerquist E, Carrico CT, Schief W

Focusing Antibody Responses to Specific Protein Surfaces Through Site-Selective Glycan Addition by Schiffner, T, Leonavicius, K, Schuster, H, Kong, L, Saliba, R, Wegmann, F, Huang, P, Stewart-Jones, G, Schief, W, Davis, B, Sattentau, Q

P05-09. 4e10 epitope-scaffolds mimic the antibody-bound epitope conformation and block neutralization by sera from rare HIV+ individuals by Strong R, Stamatatos L, Baker D, Xu C, Kalyuzhniy O, Bretz C, Sather N, Boni E, Holmes M, Correia BE, Ban YA, Schief W

P09-13. Structure of HIV-1 gp41 interactive region: layered architecture and basis of conformational mobility by Sodroski J, Schief W, Zhou T, Robinson J, Stuckey J, Kwon Y, Kong L, Huang C, Chen L, Ban Y, Majeed S, Pancera M, Wyatt R, Kwong P

Immune focusing and enhanced neutralization induced by HIV-1 gp140 chemical cross-linking. by Schiffner, T, Kong, L, Duncan, C, Back, J, Benschop, J, Shen, X, Huang, P, Stewart-Jones, G, DeStefano, J, Seaman, MS, Tomaras, G, Montefiori, D, Schief, W, Sattentau, Q

Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies. by Pritchard, L, Spencer, D, Royle, L, Bonomelli, C, Seabright, G, Behrens, A, Kulp, D, Menis, S, Krumm, S, Dunlop, D, Crispin, D, Bowden, T, Scanlan, C, Ward, A, Schief, W, Doores, K, Crispin, M

Refocussing antibody responses by chemical modification of vaccine antigens. by Schiffner, T, Leonavicius, K, Schuster, H, Kim, H, Kong, L, Saliba, R, Brod, F, Wegmann, F, Huang, P, Stewart-Jones, G, Schief, W, Ward, AB, Moore, J, Sanders, R, Davis, B, Sattentau, Q